Advertisements Of Health Products Promoted On TV

New Delhi : Minister of Information and Broadcasting; and Minister of Youth Affairs and sports Anurag Singh Thakur replied on 21.3.2023 in a Starred question No. 288 of Sanjay Sadashivrao Mandlik and Dhairyasheel Sambhajirao Mane in Lok Sabha that “Advertising Standards Council of India (ASCI) is a nonstatutory, non-Governmental, voluntary self-regulation organization of the advertising industry. Its report, guidelines etc. are available on its website i.e. https://ascionline.in/.

All advertisements telecast on private satellite TV channels are required to adhere to the Advertising Code prescribed under the Cable Television Networks (Regulation) Act, 1995 and rules framed thereunder.

For print media the Press Council of India (PCI), a statutory body established under the Press Council Act, 1978, has issued norms relating to advertisements in its ‘Norms for Journalistic Conduct’. PCI has a complaint mechanism for redressing complaints.

A Central Consumer Protection Authority (CCPA) has been established under the provisions of Consumer Protection Act, 2019 w.e.f. 24.07.2020 which inter-alia looks into misleading advertisements either suo-moto or on complaints or on directions from the Central Government. CCPA has notified ‘Guidelines for Prevention of Misleading Advertisements and Endorsements for Misleading Advertisements, 2022’ on 9th June, 2022.”

Earlier the minister replied in Unstarred Question No. 1844 answered on 22.12.2022 that “Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 and Rules thereunder provides for prohibition of misleading advertisements and exaggerated claims of drugs and medicinal substances (including AYUSH medicines). The Central Government has notified Rule 170 in the Drugs & Cosmetics Rules, 1945 on 24th December, 2018 specifically for controlling inappropriate advertisements of Ayurvedic, Siddha and Unani medicines. An institutional mechanism at the central and state levels have been set up for enforcement and taking action in case of violation.”

Ramdev-promoted FMCG company Patanjali Ayurved’s advertising promotional expenses for the fiscal ended 31st March 2021 has increased 3.26% to Rs 294.09 crore from Rs 284.79 crore in the previous fiscal, according to financial data accessed by business intelligence platform.
  • Related Posts

    • Pharma
    • April 19, 2024
    • 32 views
    US FDA Mandates Label Updates On CAR-T Cancer Therapies

    Washington: The U.S. Food and Drug Administration said on Thursday cancer therapies that use CAR-T technology will require changes to the so-called “boxed warning” to highlight the serious risk of T-cell blood…

    • Pharma
    • April 19, 2024
    • 22 views
    Karnataka Fails To Take Action Against 1,700 Fake Doctors

    Bengaluru: A startling revelation has come to light nearly 17,00 fake doctors have been identified in the AYUSH department in Karnataka. Shockingly, despite these discoveries, no significant action has been taken…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    US FDA Mandates Label Updates On CAR-T Cancer Therapies

    US FDA Mandates Label Updates On CAR-T Cancer Therapies

    Karnataka Fails To Take Action Against 1,700 Fake Doctors

    Karnataka Fails To Take Action Against 1,700 Fake Doctors

    Chhattisgarh Pharmacy Council Issued Certificates For Hundreds Of Fake Pharmacists Without Verification

    Chhattisgarh Pharmacy Council Issued Certificates For Hundreds Of Fake Pharmacists Without Verification

    Gujarat FDCA Approved 133 New Drug Manufacturing Units In FY24

    Gujarat FDCA Approved 133 New Drug Manufacturing Units In FY24

    DCGI Informs SLAs Antibiotic Combo Meropenem 1 Mg & EDTA For Injection Has No Approval

    DCGI Informs SLAs Antibiotic Combo Meropenem 1 Mg & EDTA For Injection Has No Approval

    DCA Raids Two Illegal Pharmacies; Seizes Stocks Of Over 60 Types Of Drugs

    DCA Raids Two Illegal Pharmacies; Seizes Stocks Of Over 60 Types Of Drugs